title: [Development of combined inulin/p-aminohippuric acid (PAH) slow release implantation tablets for clearance determination in awake rats].
abstract: A new method has been developed for the simultaneous measurement of Inulin and PAH clearance in small laboratory animals (rats). An implantable Inulin/p-aminohippuric-acid matrix-retard tablet based on Eudragit was tested with the purpose to estimate renal clearances. Sufficiently high serum and urine levels of both substances can thus be maintained up to 12-48 hours. The advantage of the method is that it can be used for renal clearance tests in small conscious animals, able to move freely within their cages without serious handling stress.
authors: Institut für Pharmazeutische Chemie, Karl-Franzens-Universität Graz, Osterreich.
authors: W
authors: W
authors: Korsatko
authors: A
authors: A
authors: Sadjak
authors: P
authors: P
authors: Gall
authors: S
authors: S
authors: Supanz
mesh_terms: D000618:Aminohippuric Acids; D000818:Animals; D003692:Delayed-Action Preparations; D007444:Inulin; D007668:Kidney / Q000378:metabolism; D008657:Metabolic Clearance Rate; D051381:Rats; D010130:p-Aminohippuric Acid
chemical_list: D000618:Aminohippuric Acids; D003692:Delayed-Action Preparations; D007444:Inulin; D010130:p-Aminohippuric Acid
vernacular_title: Entwicklung kombinierter Inulin/p-Aminohippursäure (PAH) Retard-Implantationstabletten zur Bestimmung der Clearance an wachen Ratten.